Outcome of Vaginal Progesterone as a Tocolytic Agent: Randomized Clinical Trial
Author(s) -
Soraya Saleh Gargari,
Malihe Habibolahi,
Zahra Zonobi,
Zahra Khani,
Fatemeh Sadat Sarfjoo,
Atefeh Kazemi Robati,
Roja Etemad,
Zohreh Karimi
Publication year - 2012
Publication title -
isrn obstetrics and gynecology
Language(s) - English
Resource type - Journals
eISSN - 2090-4444
pISSN - 2090-4436
DOI - 10.5402/2012/607906
Subject(s) - medicine , obstetrics , pregnancy , gestational age , randomized controlled trial , tocolytic agent , tocolytic , birth weight , preterm labor , clinical trial , gestation , gynecology , genetics , biology
Vaginal progesterone has a potential beneficial effect in postponing of preterm labor by suppression of prostaglandins cascades. Although different studies evaluated the use of progesterone for preterm birth, the exact effect of which on prolongation of pregnancy remains unclear. Seventy two women who underwent preterm labor were managed by magnesium sulfate. Then they were randomly assigned to continue pregnancy either by applying vaginal progesterone (400 mg) until delivery or without using any drug. Gestational age mean at the time of delivery ( P = 0.039) and postponing delivery mean time ( P = 0.048) were significantly higher in progesterone group. Comparison of neonatal outcomes between two groups of patients showed meaningful benefits of progesterone in increasing of neonatal weight, reduction of low birth weight babies, and lowing neonate admitted in NICU.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom